Drug · DIN 02171880
TIMOPTIC-XE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since October 7, 2019; first marketed December 31, 1995.
- Drug Identification Number (DIN)
- 02171880
- Company (DIN owner)
- Purdue PharmaToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution (Extended-Release)
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Timolol S01ED01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TIMOLOL (TIMOLOL MALEATE) | 0.25 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 28, 2016: NOC 18658New Drug Submission (NDS) · Transfer of drug identification numbers
- June 17, 2005: NOC 7100New Drug Submission (NDS) · Manufacturer name change
- June 21, 1995: NOC 5273Supplement to a New Drug Submission (SNDS) · New dosage form: long acting gellan solution
Other DINs named TIMOPTIC-XE
- DIN 02171899 · Marketed